Ignite Creation Date:
2025-12-24 @ 11:47 AM
Ignite Modification Date:
2026-01-01 @ 7:58 AM
Study NCT ID:
NCT03439761
Status:
UNKNOWN
Last Update Posted:
2018-03-16
First Post:
2018-02-02
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
An Open-label Phase I/II Clinical Trial of PT-112 Injection for Advanced Solid Tumors and Advanced Hepatocellular Carcinoma
Sponsor:
SciClone Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-03-07
Start Date Type:
ACTUAL
Primary Completion Date:
2020-05
Primary Completion Date Type:
ESTIMATED
Completion Date:
2020-07
Completion Date Type:
ESTIMATED
First Submit Date:
2018-02-02
First Submit QC Date:
None
Study First Post Date:
2018-02-20
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-03-14
Last Update Post Date:
2018-03-16
Last Update Post Date Type:
ACTUAL